Home Neoplasma 2007 Neoplasma Vol.54, p.285-289, 2007

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.54, p.285-289, 2007

Title: Increased monocyte chemoattractant protein 1 (MCP-1/CCL-2) serum level in acute myeloid leukemia
Author: G. MAZUR, T. WROBEL, A. BUTRYM, K. KAPELKO-SLOWIK, R. POREBA, K. KULICZKOWSKI

Abstract: Acute myeloid leukaemia (AML) is an aggressive malignancy with accumulation of blasts in bone marrow. Myeloblasts can entry into peripheral blood stream and secondary localize in extramedullary sites. The regulation of this process has not been clearly explained so far, but interactions between some chemokines and their specific receptors could be one of the mechanisms responsible for such kind of migration. Monocyte chemoattractant protein 1 (MCP-1/CCL2) is the chemokine which could be involved in this process. The aim of the study was to evaluate plasma level of CCL2 in patients with AML. Plasma samples from 65 adult patients with AML taken before chemotherapy and in complete remission were measured by enzyme linked immunoassay to evaluate CCL2 levels. Control group consisted of 15 healthy subjects. In AML patients mean baseline CCL2 level (± SEM – standard error of measurement) was significantly higher than in normal control: 365,26 ± 5,62 pg/ml vs 265,56 ± 5,48 pg/ml respectively (p

Keywords: MCP-1/CCL2, acute myeloid leukaemia, chemokines
Year: 2007, Volume: 54, Issue: Page From: 285, Page To: 289

Price: 12.00 €






© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.